Tilray (TLRY) is set to release first-quarter fiscal 2022 earnings on October 7. Tilray is a cannabis-based pharmaceutical company located in Canada. The firm intends to operate in the United States, once the federal government legalizes marijuana. Over the past year, shares of the company have gained over 126%, trading at $11.10.  Strong earnings may boost Tilray stock even more, so let's see what analysts are forecasting. Analysts on average expect Tilray to post loss of $0.06 per share and revenues of $178.80 million for fiscal Q1. Meanwhile, the Earnings Whisper number, or the Street’s unofficial view on earnings, stands at a loss of $0.09 per share.
https://www.tipranks.com/news/article/tilray-q1-earnings-preview-whats-ahead?utm_source=advfn.com&utm_medium=referral
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Tilray Brands Charts.
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Tilray Brands Charts.